11.49
CorMedix Inc stock is traded at $11.49, with a volume of 1.81M.
It is down -0.09% in the last 24 hours and down -23.25% over the past month.
CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey.
See More
Previous Close:
$11.50
Open:
$11.48
24h Volume:
1.81M
Relative Volume:
0.92
Market Cap:
$779.31M
Revenue:
$65,400
Net Income/Loss:
$-46.34M
P/E Ratio:
-12.49
EPS:
-0.92
Net Cash Flow:
$-38.74M
1W Performance:
+5.80%
1M Performance:
-23.25%
6M Performance:
-7.49%
1Y Performance:
+143.95%
CorMedix Inc Stock (CRMD) Company Profile
Name
CorMedix Inc
Sector
Industry
Phone
908-517-9500
Address
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Compare CRMD with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CRMD
CorMedix Inc
|
11.49 | 855.94M | 65,400 | -46.34M | -38.74M | -0.92 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-30-25 | Downgrade | D. Boral Capital | Buy → Hold |
Jun-30-25 | Initiated | H.C. Wainwright | Buy |
Mar-07-25 | Initiated | Leerink Partners | Outperform |
Jan-13-25 | Initiated | D. Boral Capital | Buy |
Aug-26-24 | Initiated | Rodman & Renshaw | Buy |
Aug-10-23 | Initiated | RBC Capital Mkts | Outperform |
Feb-17-21 | Initiated | Needham | Buy |
Sep-29-20 | Initiated | JMP Securities | Mkt Outperform |
Sep-21-20 | Initiated | Truist | Buy |
Dec-18-19 | Initiated | B. Riley FBR | Buy |
Mar-26-19 | Reiterated | H.C. Wainwright | Buy |
Dec-06-18 | Initiated | ROTH Capital | Buy |
Sep-25-17 | Reiterated | H.C. Wainwright | Buy |
Aug-10-17 | Reiterated | Rodman & Renshaw | Buy |
May-05-17 | Reiterated | Rodman & Renshaw | Buy |
Nov-11-16 | Reiterated | FBR & Co. | Outperform |
Mar-17-16 | Reiterated | FBR Capital | Outperform |
Mar-03-16 | Initiated | FBR Capital | Outperform |
Nov-16-15 | Reiterated | ROTH Capital | Neutral |
Oct-29-15 | Reiterated | ROTH Capital | Neutral |
May-06-15 | Downgrade | ROTH Capital | Buy → Neutral |
Dec-08-14 | Reiterated | ROTH Capital | Buy |
Oct-03-11 | Downgrade | Maxim Group | Buy → Hold |
View All
CorMedix Inc Stock (CRMD) Latest News
Why CorMedix Inc. stock attracts strong analyst attentionFree Stock Market Courses - Metal.it
What drives CorMedix Inc. stock priceExceptional earning trajectories - Autocar Professional
What makes CorMedix Inc. stock attractive to long term investorsHigh-profit trading signals - jammulinksnews.com
What analysts say about CorMedix Inc. stockFree Predictions - PrintWeekIndia
Federal judge withdraws opinion after lawyer points out fake quotes, misstated case outcomes - ABA Journal
CorMedix’s DEFENCATH® Study: A Potential Game-Changer in Infection Prevention - MSN
CorMedix (CRMD) Soars 5.1%: Is Further Upside Left in the Stock? - Yahoo Finance
NJ Fed. Judge Pulls Opinion Flagged With Nonexistent Quotes - Law360
Judge Scraps Opinion After Lawyer Flags Made-Up Quotes (Correct) - Bloomberg Law News
CorMedix Inc. Stock Analysis and ForecastFree Stock Market Beginners Guide - Autocar Professional
Is CorMedix Inc. a good long term investmentDynamic investment growth - jammulinksnews.com
CorMedix Inc. (CRMD) Plunges 1.90% to 2025 Low - AInvest
CorMedix Inc. (CRMD) Stock Analysis: Biotech's Hidden Gem With 71.64% Potential Upside - DirectorsTalk Interviews
What makes CorMedix Inc. stock price move sharplyFree Consultation - Newser
How CorMedix Inc. stock performs during market volatilityHigh Potential Safe Trades - Newser
CorMedix soars on increased Q2 sales guidance - MSN
Can CorMedix (CRMD) Keep the Earnings Surprise Streak Alive? - Yahoo Finance
CorMedix Inc. Advances Pediatric Dialysis Safety with New Clinical Study - TipRanks
(CRMD) Investment Analysis and Advice - news.stocktradersdaily.com
Important Notice to Long-Term Shareholders of CorMedix Inc. - GlobeNewswire
RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $18 - 富途牛牛
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on - GlobeNewswire
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. ... - Bluefield Daily Telegraph
CorMedix Completes $82.2 Million Stock Offering - The Globe and Mail
CorMedix stock rating downgraded to Hold from Buy by D. Boral Capital - Investing.com
CorMedix stock rating reiterated as Buy by H.C. Wainwright - Investing.com India
This CorMedix Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday - Benzinga
CorMedix slides after pricing $85M stock offering - MSN
CorMedix Inc Stock (CRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):